: Fresh off IPO, ‘biofacturing’ company Zymergen’s stock plunges about 70% after some really bad news
Less than four months after going public and being valued at more than $3 billion by Wall Street, Zymergen Inc. unleashed some bad news Tuesday afternoon and was on pace to lose more than two-thirds of its market cap.
—————
TRANSCOM ISP – Free Sigma HSE Email
Level 6 Domain Names are FREE – Register Now.